Ibex Biosciences
Biologics & Biosimilars · Cell & Gene Therapy
$5.2Mtotal raised · 5 rounds on record
$70klatest round · Venture round · Feb 2025 · 21 mo ago
$300kgrants · 1 grant · CORDIS
10+team · employees, estimated range
Overview
Ibex Biosciences is a biotech company that boasts a diverse portfolio encompassing therapeutic antibodies, gene therapies, and regenerative medicine programs.
Key facts
These are the key facts about Ibex Biosciences on Alion as of Nov 13, 2026. Ibex Biosciences is headquartered in Rockville, United States. It was founded in 2017. It has raised $5.2M in 4 funding rounds. The latest round is Venture - Series Unknown of $70k, announced in 2025.
- Headquarters
- Rockville, United StatesAlion company profile, updated Nov 8, 2026
- Founded
- 2017Alion company profile, updated Nov 8, 2026
- Employees
- 10+Alion company profile, an estimated range
- Total raised
- $5.2MSum of 4 equity rounds Alion knows
- Latest round
- Venture - Series Unknown · $70k · Feb 5, 2025SEC Form D filing · sec.gov
- Visa sponsorship, United States
- 1 · H-1B filings in 12 monthsUS Department of Labor · latest filing Jun 9, 2026
Official records
Funding and backers
Total raised
$5.2M
5 rounds on record
Latest round
$70k
Venture round · Feb 2025 · 21 mo ago
Team
11-50
employees, estimated range
Grants
$300k
1 grant · CORDIS
The money's age
Due for its next round
21 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 5, 2025
Raised a round Venture round $70k · SEC Form D
Jul 5, 2021
Raised a round Venture round $1M · SEC Form D
Sep 25, 2018
Raised a round Venture round $2.4M · SEC Form D
Sep 20, 2017
Won a grant $300k · CORDIS
2017
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Feb 2025 | $70k | — | SEC Form D |
| Venture round | Jul 2021 | $1M | — | SEC Form D |
| Venture round | Sep 2018 | $2.4M | — | SEC Form D |
| Grant | Sep 2017 | $300k | — | CORDIS |
| Venture round | Aug 2017 | $1.8M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Ibex Biosciences, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Alberto CrociExecutive Officer, DirectorSEC Form D
Michael KarlinExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
0 At Nextgen Biologics, we are dedicated to advancing the future of regenerative medicine through science inspired by nature. Our work…
Theradaptive aims to redefine the regenerative medicine field by delivering therapeutics to any location in the body with precision.
Benefits platform for cell and gene therapies designed to provide sustainable access to life-saving medicines.
Stately Bio is developing the next generation of life-saving regenerative medicines with the world.
Instant Quantification of genetic modifications for Cell and Gene Therapies.
Capsida Biotherapeutics is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies…
Visa sponsorship
1
H-1B filings in 12 months
1
Green card filings
$58k
Median offered salary
Who they sponsor
Biological technicians
1
In the register as Ibex Biosciences, Inc., North Bethesda, MD (+1 more)
Other sponsors in the same field
Kashiv Biosciences 
ImmunityBio 
Adimab
Alert me
US Department of Labor · latest filing Jun 9, 2026 · Visa details by country
Financials
Total raised
$5.5M
Latest round
Venture - Series Unknown
Funding rounds
5
People
Alberto Croci
Executive Officer, Director
Michael Karlin
Executive Officer, Director
Roy Feinson
Director
Sylvan Karlin
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
3
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Rockville
United States
HQ
North Bethesda
United States
Regional office
Thank you for your interest in Ibex Biosciences. To contact us, use the form below:
How to cite this page
Alion, "Ibex Biosciences: key facts", as of Nov 13, 2026. https://alion.io/company/ibex-biosciences
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0